Skip to main content
CareerApp
Gilead Sciences

Director, Nonclinical Safety, Pathology

Gilead Sciences

United States - California - Foster City · Director

$226,185 – $292,710

Listed on Gilead Sciences’s own careers site. You apply with them directly — we never stand between you and the employer.

What this role is

Gilead is seeking a veterinary anatomic pathologist to interpret pathology findings and provide scientific support for drug development across discovery, preclinical studies, and marketed products. This role suits experienced pathologists who want to lead cross-functional teams and contribute to regulatory strategy while mentoring junior scientists in a fast-paced biopharmaceutical environment.

Our summary, not Gilead Sciences’s wording. The full posting is on their site.

Skills this role names

Log in to see which of these are already on your profile.

What they ask for

Required

  • DVM degree
  • Anatomic pathology residency training
  • Specialty board certification in anatomic pathology
  • 3–7 years relevant experience
  • Strong decision-making and complex problem-solving
  • Critical data analysis and interpretation
  • Excellent verbal and written communication skills
  • Scientific productivity demonstrated through publications or presentations

Nice to have

  • PhD or post-doctoral experience in comparative pathology, toxicology, or related field
  • Previous industry experience in biopharmaceutical pathology
  • Project pathologist experience in biopharmaceutical industry
  • Deep experience in immunology, virology, or oncology
  • Mentoring and developing junior scientists
  • Experience representing pathology in external scientific forums and regulatory interactions
  • Working knowledge of digital pathology, image analysis, and AI

Turn on analytics and we load Google Analytics: Google gets the pages you open and what you do here — searches, jobs you view, jobs you apply to — and sets its own cookies. Leave it off and the only cookies we set are your login, your theme, and this answer. Accept All also records a yes to advertising, which nothing uses yet. Privacy Policy.